Skip to main content
. Author manuscript; available in PMC: 2007 Jun 15.
Published in final edited form as: J Immunol. 2006 Aug 15;177(4):2304–2313. doi: 10.4049/jimmunol.177.4.2304

Table I.

Regulation of TRAIL receptors by HIV-1 infection and TRAIL treatmenta

Control TRAIL HIV TRAIL ± HIV
TRAIL R1 54.91 ± 9.15 54.12 ± 6.65 50.37 ± 7.548 50.25 ± 8.51
TRAIL R2 59.9 ± 17.1 58.62 ± 15.56 56.12 ± 18.36 61.28 ± 13.48
TRAIL R3 48.82 ± 10.88 39.68 ± 8.11 42.86 ± 7.73 55.53 ± 15.13
TRAIL R4 64.99 ± 18.38 50.7 ± 11.59 51.7 ± 11.34 38.91 ± 7.4
a

Data are mean fluorescent intensities ± SEM of different TRAIL receptors assessed by FACS (see Fig. 4). Data analyzed by ANOVA showed no statistically significant differences between any of the treatment groups for any TRAIL receptors.